Palvella Therapeutics Inc. (PVLA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palvella Therapeutics Inc...

    NASDAQ: PVLA · Real-Time Price · USD
    67.45
    1.67 (2.54%)
    At close: Oct 06, 2025, 2:49 PM

    Palvella Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a 1.3M 19.52M 20.05M 1.94M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a 739K 725K 571K
    Gross Profit
    		 n/a n/a n/a n/a n/a 1.3M 18.78M 19.33M 1.36M
    Operating Income
    		 -9.25M -7.87M -3.13M -4.18M -1.76M -5.48M 3.09M 2.06M -15.51M
    Interest Income
    		 690K 752K 169K n/a 86K 455K 549K 490K 357K
    Pretax Income
    		 -9.47M -8.19M -2.89M -3.59M -2.54M -4.58M -10.75M 3.98M -13.18M
    Net Income
    		 -9.47M -8.19M -2.89M -3.59M -2.54M -4.58M -10.75M 3.98M -13.18M
    Selling & General & Admin
    		 4.13M 3.8M 3.58M 3.43M 775K 2.33M 6.1M 3.7M 4.06M
    Research & Development
    		 5.12M 4.07M -446K 751K 984K 4.45M 9.6M 13.57M 12.82M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 9.25M 7.87M 3.13M 4.18M 1.76M 6.78M 15.7M 17.27M 16.88M
    Interest Expense
    		 1.35M 1.22M n/a 1.06M 805K n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 9.25M 7.87M 3.13M 4.18M 1.76M 6.78M 16.43M 17.99M 17.45M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 11.05M 2.23M 1.32M 1.3M 1.27M 1.24M 1.24M 1.09M 11.22M
    Shares Outstanding (Diluted)
    		 11.05M 2.23M 1.32M 1.3M 1.27M 1.24M 1.24M 1.1M 11.22M
    EPS (Basic)
    		 -0.86 -3.68 -2.19 -2.76 -2 -3.71 -8.7 3.63 -0.62
    EPS (Diluted)
    		 -0.86 -3.68 -2.19 -2.76 -2 -3.71 -8.7 3.62 -0.62
    EBITDA
    		 -8.12M -6.97M -2.89M -3.59M -1.73M -4.58M -10.01M 4.7M -12.61M
    EBIT
    		 -8.12M -6.97M -2.89M -3.59M -1.73M -4.58M -10.75M 3.98M -13.18M
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a 739K 725K 571K

    Add to Watchlist